0.8 PLN
8.23 M PLN
618.55 M PLN
13.67 M
About ENELMED
Sector
Industry
CEO
Jacek Jakub Rozwadowski
Website
Headquarters
Warsaw
Founded
1993
ISIN
PLENLMD00017
FIGI
BBG001PFXQF6
Centrum Medyczne Enel Med SA engages in the provision of medical services. It includes dentistry, medical consultations, ultrasound, genetic research, vaccinations, laboratory tests, ophthalmology center, resonance imaging, tomograph, hospital, rehabilitation, apnea, snoring, and endoscopy. It operates through the following brands: estell, enel-sport, enelsenior, enelzdrowie, medispot, and enel-med dentistry The company was founded by Adam Stanislaw Rozwadowski in 1993 and is headquartered in Warsaw, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENE is 20.0 PLN — it hasn't changed in the past 24 hours. Watch ENELMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange ENELMED stocks are traded under the ticker ENE.
ENE stock has risen by 0.50% compared to the previous week, the month change is a 0.50% rise, over the last year ENELMED has showed a 8.11% increase.
ENE stock is 0.00% volatile and has beta coefficient of −0.04. Track ENELMED stock price on the chart and check out the list of the most volatile stocks — is ENELMED there?
Today ENELMED has the market capitalization of 565.61 M, it has increased by 6.38% over the last week.
Yes, you can track ENELMED financials in yearly and quarterly reports right on TradingView.
ENE net income for the last quarter is 12.63 M PLN, while the quarter before that showed 1.90 M PLN of net income which accounts for 563.99% change. Track more ENELMED financial stats to get the full picture.
No, ENE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENELMED EBITDA is 90.82 M PLN, and current EBITDA margin is 10.27%. See more stats in ENELMED financial statements.
Like other stocks, ENE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENELMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENELMED technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENELMED stock shows the buy signal. See more of ENELMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.